Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invitation Homes Inc. Common Stock (INVH) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Invitation Homes Inc. Common StockTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Invitation Homes Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Invitation Homes Inc. Common Stock trades at $26.54 (market cap $15.70B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Invitation Homes Inc. Common Stock is far larger — about 8.7× Vir Biotechnology Inc. Common Stock's market cap, and Invitation Homes Inc. Common Stock pays a 4.51% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Invitation Homes Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

INVHVIR
Market Cap
$15.70B$1.80B
Volume
4,685,4161,782,836
Sector
Real EstateHealth
52-Week High
$30.59$11.78
52-Week Low
$24.39$5.12
Typical Hold Time
0 Days0 Days
Enterprise Value
$24.16B$1.36B
Dividend Yield
4.51%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invitation Homes Inc. Common Stock

INVH trades at $26.59, down 0.41% on the day, with neutral technical signals and strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results expected soon. Revenue growth from $2.73B in 2025 to $2.9B projected for 2026 supports a solid profit margin expansion to 23.13%. Analyst consensus remains bullish with a $31.67 price target, representing 19% upside potential from current levels.

The investment case centers on INVH's consistent earnings outperformance and robust single-family rental demand, though rising interest rates pose headwinds. With 56% of analysts recommending Buy and institutional accumulation continuing, the stock offers value at current levels despite technical consolidation. Key risks include interest rate sensitivity and regulatory changes affecting institutional homebuying.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INVH
100% Buy0% Sell
Avg holding period · 0 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Invitation Homes Inc. Common Stock

Invitation Homes Inc. is a real estate investment trust that acquires, renovates, and leases single-family rental homes across roughly 19 US markets concentrated in Western and Southeastern US. It manages its portfolio through a pod-based local operating model supported by a maintenance technology platform.

Read more on INVH →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →